Journal of Clinical Medicine, Volume 14, Issue 22
2025 November-2 - 369 articles
Cover Story: Topical tretinoin is a first-generation retinoid with well-established efficacy in acne and photoaging. Its pleiotropic actions on epidermal differentiation, inflammation, pigmentation and collagen remodeling support a broad range of dermatologic uses. This review summarizes evidence from clinical trials and prospective studies published between 2000 and 2025, including FDA-approved indications and expanding off-label applications. Beyond acne and photoaging, tretinoin shows potential benefits in melasma, post-inflammatory hyperpigmentation, acanthosis nigricans, striae distensae, scarring, flat warts, alopecia, actinic keratosis and field cancerization. Overall, tretinoin remains a versatile, well-tolerated therapy with growing relevance in modern dermatology. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.